IMMUNATE 500 IU FVIII / 375 IU VWF I.V. VIAL

IMMUNATE is a coagulation factor VIII / von Willebrand factor complex made from human plasma. The coagulation factor VIII in IMMUNATE replaces the factor VIII which is lacking or is not functioning properly in haemophilia A. Haemophilia A is a sexlinked hereditary blood coagulation defect due to reduced factor VIII levels. This results in severe bleeding in joints muscles and inner organs either spontaneously or as a consequence of accidental or surgical traumata. The administration of IMMUNATE temporarily corrects the factor VIII deficiency and reduces the bleeding tendency. In addition to its role as a Factor VIII protecting protein von Willebrand Factor (VWF) mediates platelet adhesion to sites of vascular injury and plays a role in platelet aggregation. IMMUNATE is used for the treatment and prevention of bleeding in congenital (haemophilia A) or acquired factor VIII deficiency. IMMUNATE is also used in von Willebrand�s disease with factor VIII deficiency.